CDF Press

RSS feed for this section

FDA Defines “Gluten-Free” for Food Labeling

Celiac Disease Foundation Applauds FDA Food Labeling Rule Defining “Gluten-Free.” By August of 2014, all FDA-regulated foods labeled “Gluten-Free” must contain less than 20 ppm of gluten or manufacturers face regulatory enforcement. The rule is long awaited good news for those with celiac disease. There is an undeniable air of excitement at the national Celiac […]

CDF quoted in Press Release for Gluten-Free Dating Website

Our Operations / Communications Director, Hillary Kane, was quoted as GlutenFreeSingles.com launches its new online dating site. “There is a time and a place to educate food-servers, restaurateurs and dining partners about the danger of cross-contamination and villi damage from gluten…a first date, is not that place or time,” said Hillary Kane,communications director of the […]

CDF Medical Advisory Board Member Alessio Fasano Co-Authors Study on Stem Cell Pathways in Acute Celiac Disease

Expression Analysis of Intestinal Stem Cell Signaling Pathways in Acute Celiac Disease Background: Celiac disease is an autoimmune disease triggered by ingestion of gluten, the key proteic component of wheat, in genetically predisposed individuals. The intestinal mucosa presents lesions with varying degrees of inflammation secondary to the autoimmune insult characterized by villous atrophy and crypts […]

Drs. Joseph Murray and Peter Green [CDF Medical Avisory Board] are Among Esteemed Authors of LPM in Celiac Disease Study

Mucosal Healing and Risk of Lymphoproliferative Malignancy in Celiac Disease Outcomes Background: Celiac disease (CD) is associated with an increased risk of lymphoproliferative malignancy (LPM). It is unknown whether this risk is affected by the results of the follow-up intestinal biopsy, performed to document mucosal healing. We aimed to quantify the risk of LPM in […]

Dr. Peter Green [CDF Medical Advisory Board] Co-Authors Study on Mucosal Healing / Fracture Risk in Celiac Disease

Background: Celiac disease (CD) is associated with an increased risk of osteoporotic fracture, a risk increase that persists after diagnosis. Although the gluten-free diet results in an improvement of symptoms in the majority of patients, a significant proportion have persistent villous atrophy (VA) on follow-up biopsy. It is unknown whether persistent VA impacts long-term fracture […]